UMBRALISIB vs UPADACITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
UMBRALISIB vs UPADACITINIB: Safety Overview
| Metric | UMBRALISIB | UPADACITINIB |
|---|---|---|
| Total FAERS Reports | 293 | 65,656 |
| Deaths Reported | 30 | 2,406 |
| Death Rate | 10.2% | 3.7% |
| Hospitalizations | 97 | 15,931 |
| Average Patient Age | 69.0 yrs | 57.4 yrs |
| % Female Patients | 43.8% | 71.2% |
| FDA Approval Date | Feb 5, 2021 | Apr 26, 2024 |
| Manufacturer | N/A | AbbVie Inc. |
| Route | N/A | ORAL |
| Marketing Status | Discontinued | Prescription |